Freshpet (FRPT)
(Delayed Data from NSDQ)
$139.53 USD
+0.24 (0.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $139.57 +0.04 (0.03%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$139.53 USD
+0.24 (0.17%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $139.57 +0.04 (0.03%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Zacks News
Mondelez (MDLZ) Q2 Earnings Beat, Organic Revenues Up 2.5%
by Zacks Equity Research
Mondelez (MDLZ) posts soft sales in second-quarter 2024, whereas organic revenues grow 2.5%. Strong pricing and cost management actions also fuel bottom-line growth.
Is BRF (BRFS) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how BRF (BRFS) and Freshpet (FRPT) have performed compared to their sector so far this year.
Kraft Heinz (KHC) Tops Q2 Earnings Estimates
by Zacks Equity Research
Kraft Heinz (KHC) delivered earnings and revenue surprises of 6.85% and 0.93%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Freshpet (FRPT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Freshpet (FRPT) reachead $118.52 at the closing of the latest trading day, reflecting a -1.61% change compared to its last close.
Archer Daniels (ADM) Q2 Earnings & Revenues Miss, Down Y/Y
by Zacks Equity Research
Archer Daniels (ADM) reports lower revenues year over year in second-quarter 2024 owing to a decline in sales across its segments.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Can Clorox's (CLX) Pricing & Cost-Saving Plan Aid Q4 Earnings?
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from pricing strategies and cost-saving initiatives, as well as progress on the IGNITE strategy, amid high SG&A expenses.
Freshpet (FRPT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Freshpet (FRPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Take the Zacks Approach to Beat the Markets: Chewy, Pitney Bowes, 3M in Focus
by Santanu Roy
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Newell's (NWL) Q2 Earnings Beat Mark, Soft Core Sales Hurt
by Zacks Equity Research
Newell (NWL) reports a sales decline in second-quarter 2024, owing to a core sales drop of 4.2% year over year.
Colgate (CL) Stock Gains on Q2 Earnings Beat, '24 EPS View Hike
by Zacks Equity Research
Colgate's (CL) Q2 results reflect continued gains in volume and pricing, offset by greater negative impacts of currency, leading to robust organic sales growth. CL raises the adjusted EPS view for 2024.
FEMSA (FMX) Posts Sturdy Q2 Growth: Revenues & Earnings Up Y/Y
by Zacks Equity Research
FEMSA (FMX) Q2 results showcase broad-based growth across its business units and an improved operating margin despite adverse weather conditions and strong year-over-year comparisons.
Keurig (KDP) Q2 Earnings Meet Estimates, Volumes Drive Sales
by Zacks Equity Research
Keurig's (KDP) second-quarter 2024 results reflect impressive net sales trends, considerable margin growth and solid earnings improvement.
Lamb Weston (LW) Q4 Earnings & Sales Lag Estimates, Down Y/Y
by Zacks Equity Research
Lamb Weston's (LW) fourth-quarter fiscal 2024 results reflect lower earnings and sales on more-than-anticipated market share losses and a slowdown in restaurant traffic.
Inter Parfums' (IPAR) Q2 Sales Rise on Robust Fragrance Demand
by Zacks Equity Research
Inter Parfums' (IPAR) sales have increased year over year in second-quarter 2024, driven by ongoing momentum in the fragrance market.
Philip Morris (PM) Ups View on Q2 Earnings Beat: Pricing Aids
by Zacks Equity Research
Philip Morris' (PM) second-quarter 2024 results reflect continued strength in pricing and the company's smoke-free business. Management raises guidance despite adverse currency fluctuations.
Service Corporation (SCI) Thrives on Cemetery Unit, Growth Drive
by Zacks Equity Research
Service Corporation (SCI) benefits from strength in its Cemetery segment and a focus on strengthening its network.
Coca-Cola (KO) Advances on Q2 Earnings Beat, Higher Forecast
by Zacks Equity Research
Coca-Cola's (KO) Q2 results highlight the benefits of an enhanced price/mix and rising concentrate sales, driven by regional growth and improved margins boosting profits.
Kimberly-Clark (KMB) Tops Q2 Earnings Estimates, Ups FY24 View
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter 2024 results reflect higher earnings on increased operating profit. Taking into account solid first-half results, management raised its annual profit view.
Monster Beverage (MNST) Stock Slides YTD: Is Recovery Likely?
by Zacks Equity Research
Monster Beverage (MNST) looks well-poised for long-term growth, backed by strength in its energy drinks business, continued innovation and product launches.
Philip Morris' (PM) New Investment to Fuel Smoke-Free Growth?
by Zacks Equity Research
Philip Morris' (PM) announcement of a $600 million investment to establish a manufacturing facility in Aurora, CO, presents several strategic advantages and promising growth opportunities.
Inter Parfums (IPAR) Gains on the Burgeoning Fragrance Market
by Zacks Equity Research
Continued momentum in the fragrance market and the successful product launches are driving Inter Parfums' (IPAR) growth story.
McCormick (MKC) Benefits From Brand Strength & Cost Savings
by Zacks Equity Research
With a global portfolio aligned with consumer trends and innovative product platforms, McCormick's (MKC) focus on growth areas and efficiency bolsters its market presence.
Energizer (ENR) Up 8.5% in 3 Months: How to Play Ahead?
by Zacks Equity Research
Energizer's (ENR) robust growth and financial health making it an attractive investment opportunity. Its strategic initiatives, particularly Project Momentum, have significantly improved cost efficiency and profitability.
Medifast (MED) Lags Industry in 3 Months: How to Play Ahead?
by Zacks Equity Research
While Medifast (MED) is implementing a series of measures to propel its growth trajectory, the challenges related to customer acquisition and high marketing expenses keep it in a tight spot.